ATDBio

ATDBio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.5M

Overview

ATDBio is a private, revenue-generating service provider and partner in the oligonucleotide synthesis space, headquartered in Southampton, UK. The company's core business is providing custom, high-purity oligonucleotides and associated technical support to research, diagnostic, and therapeutic development clients. Its differentiation lies in deep chemical insight, flexibility in handling complex modifications, and a collaborative partnership model, as evidenced by strategic collaborations with companies like YouSeq and NATA. ATDBio operates primarily as a B2B service provider rather than developing its own therapeutic pipeline.

Genetics & GenomicsSynthetic BiologyDiagnostics

Technology Platform

Deep expertise in oligonucleotide chemistry enabling optimal design, synthesis (including complex modifications), purification, and analysis for high-purity yield.

Funding History

2
Total raised:$3.5M
Seed$3M
Grant$500K

Opportunities

The rapid growth of nucleic acid therapeutics (antisense, siRNA) and molecular diagnostics creates expanding demand for high-quality, complex oligonucleotide synthesis.
Leadership in difficult modifications and a partnership model allows ATDBio to embed itself deeply in clients' R&D, moving up the value chain.
The synthetic biology revolution offers a new, long-term market for custom DNA as a programmable material.

Risk Factors

Competition from large, scaled oligo suppliers and potential technological disintermediation from cheaper, easier synthesis methods.
Reliance on a limited number of strategic partners for significant revenue.
Operational and supply chain risks associated with being a single-site UK company post-Brexit.

Competitive Landscape

ATDBio competes with large, high-volume oligo suppliers like Integrated DNA Technologies (IDT) and Merck (Sigma-Aldrich), as well as other specialty CROs. Its differentiation is a deep focus on chemical insight, flexibility for complex/modified oligos, and a collaborative service model, rather than competing on price for standard, high-volume orders.